 |
 |
|
|
RESÚMENES ABRIL 2005 |
Addictive Disorders
(Requiere
estar conectado a internet. Haga un click en la información del journal)
G. S. Rajesh, Ed Day
Psychiatric Bulletin (2005) 29: 141-143
Jason Schiffman,
Brad Nakamura, Mitchell Earleywine and Joseph LaBrie
Psychiatry Research. Volume 134, Issue 1, 30 March
2005, Pages 37-42
Efficacy and Tolerability of Long-Acting Injectable Naltrexone
for Alcohol Dependence
A Randomized Controlled Trial
James C. Garbutt,
Henry R. Kranzler, Stephanie S. O’Malley, David R. Gastfriend, Helen M.
Pettinati, Bernard L. Silverman, John W. Loewy, Elliot W. Ehrich, for the
Vivitrex Study Group
The role of the
NMDA receptor in alcohol relapse: a pharmacological mapping study using the
alcohol deprivation effect
Valentina
Vengeliene, Daniel Bachteler, Wojciech Danysz and Rainer Spanagel
Neuropharmacology. Volume 48, Issue 6, May 2005, Pages
822-829
Fluoxetine in
adolescents with comorbid major depression and an alcohol use disorder: a
3-year follow-up study
Jack R. Cornelius,
Duncan B. Clark, Oscar G. Bukstein, Thomas M. Kelly, Ihsan M. Salloum and D.
Scott Wood
Addictive
Behaviors. Volume 30, Issue 4, May 2005, Pages 807-814
Relations between
cannabis use and dependence, motives for cannabis use and anxious, depressive
and borderline symptomatology
Henri Chabrol,
Emmanuelle Ducongé, Carine Casas, Charlotte Roura and Kate B. Carey
Addictive
Behaviors. Volume 30, Issue 4, May 2005, Pages 829-840
A comparison of
the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”)
with cocaine in rhesus monkeys
Joshua A. Lile,
Jason T. Ross and Michael A. Nader
Drug and Alcohol Dependence. Volume 78, Issue 2, 9 May
2005, Pages 135-140
Experience of emotions
in substance abusers exposed to images containing neutral, positive, and
negative affective stimuli
Francisco Aguilar
de Arcos, Antonio Verdejo-García, María Isabel Peralta-Ramírez, María
Sánchez-Barrera and Miguel Pérez-García
Drug and Alcohol Dependence. Volume 78, Issue 2, 9 May
2005, Pages 159-167
Ryan Vandrey, Alan
J. Budney, Jody L. Kamon and Catherine Stanger
Drug and Alcohol Dependence. Volume 78, Issue 2, 9 May
2005, Pages 205-210
Angelo M. Del Re
and John J. Woodward
Drug and Alcohol Dependence. Volume 78, Issue 2, 9 May
2005, Pages 221-224
Miriam Z. Mintzer,
Marc L. Copersino and Maxine L. Stitzer
Drug and Alcohol Dependence. Volume 78, Issue 2, 9 May
2005, Pages 225-230
Gabor
Oroszi; David Goldman
Pharmacogenomics. 2004, vol. 5, no. 8, pp. 1037 - 1048
Manit Srisurapanont
and Ngamwong Jarusuraisin
The International Journal of Neuropsychopharmacology
(2005), 8:2:267-280
Effects of
isradipine, a dihydropyridine-class calcium-channel antagonist, on
d-methamphetamine's subjective and reinforcing effects
Bankole
A. Johnson, John D. Roache, Nassima Ait-Daoud,
Christopher Wallace, Lynda Wells, Michael Dawes and
Yanmei Wang
The International Journal of Neuropsychopharmacology
(2005), 8:2:203-213
Risk of Becoming Cocaine Dependent: Epidemiological Estimates
for the United States, 2000-2001
Megan S O'Brien and James C
Anthony
Neuropsychopharmacology (2005) 30, 1006-1018
Neurological and Cognitive Recovery Following Abstinence from
Petrol Sniffing
Sheree Cairney, Paul Maruff, Chris
B Burns, Jon Currie and Bart J Currie
Neuropsychopharmacology (2005) 30, 1019-1027
Sarah
W Book; Hugh Myrick
Expert Opinion on Investigational Drugs. 2005, vol. 14, no. 4, pp.
371 - 376
Double-blind
placebo-controlled trial of fluoxetine in smoking cessation treatment including
nicotine patch and cognitive-behavioral group therapy
Saules KK, Schuh LM, Arfken CL, Reed K, Kilbey MM, Schuster CR
Am J Addict. 2004 Oct-Dec;13(5):438-46
CRIPPA, José
Alexandre, LACERDA, Acioly L T, AMARO, Edson et al.
Rev. Bras. Psiquiatr., Mar. 2005, vol.27, no.1,
p.70-78
Pharmacopsychiatry. 2005 May;38(3):113-7
A screening
study of antidepressant treatment rates and mood symptoms in pregnancy
S. M. Marcus,
H. A. Flynn, F. Blow and K. Barry
Archives
of Women's Mental Health 2005; Volume 8, Number 1: 25 - 27
Exposure
measures applied to the bioequivalence of two sustained release formulations of
bupropion
Midha KK, Rawson MJ, McKay G, Hubbard JW
Int J Clin Pharmacol Ther. 2005 May;43(5):244-54
Lachlan A.
McWilliams, Brian J. Cox and Gordon J.G. Asmundson
Journal
of Anxiety Disorders. Volume 19, Issue 6, 2005, Pages 626-641
Gail A. Bernstein,
Ann E. Layne, Elizabeth A. Egan and Lara P. Nelson
Journal
of Anxiety Disorders. Volume 19, Issue 6, 2005, Pages 658-672